By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA), said second quarter revenue rose 43% to a record $6.9 million, and $12.7 million in the first half of 2023. Gross margins remained at 54% for the quarter, the company said in a statement. The maker of an alternative to CPAP machines said it completed development a product […]
ProSomnus, Inc. (Nasdaq: OSA) makes precision-care oral appliance to treat obstructive sleep apnea About 1 billion global sufferers of obstructive sleep apnea, potentially life-threatening disease with adverse health effects […]